We continue to increase our reach and access in India, say Sun Pharma execs
Senior Sun Pharma executives speak on a two-pronged strategy for the China market, beginning R&D of biosimilar products, and more TopicsSun Pharma | Companies | Q1 results Sohini Das Last Updated at July 31, 2022 21:59 IST (From left) Sun Pharmaceutical Industries CFO C S Muralidharan, and CEO, India…
Stay connected